Cathie Wood Doubled Her Stakes in These 5 Stocks in 2022

3. Burning Rock Biotech Limited (NASDAQ:BNR)

Number of Hedge Fund Holders: 11

Percentage Increase in Stake During Q1: 315%

Burning Rock Biotech Limited (NASDAQ:BNR) is a China-based biotech firm. The company posted earnings for the fourth quarter of 2021 in late March, reporting a revenue of more than $23 million, up over 14% compared to the revenue over the same period last year. Yusheng Han, the CEO of the company, said during the earnings call that the company had become a “market leader” in the therapy selection business and had laid a “good foundation” for the firm moving forward in the pharma industry. 

At the end of the first quarter of 2022, ARK Investment Management owned over 3.5 million shares of Burning Rock Biotech Limited (NASDAQ:BNR) worth $32.6 million, representing 0.13% of the portfolio. 

Among the hedge funds being tracked by Insider Monkey, New York-based firm OrbiMed Advisors is a leading shareholder in Burning Rock Biotech Limited (NASDAQ:BNR), with 1.4 million shares worth more than $13 million.